| 000 | 01846 a2200517 4500 | ||
|---|---|---|---|
| 005 | 20250517060827.0 | ||
| 264 | 0 | _c20160815 | |
| 008 | 201608s 0 0 eng d | ||
| 022 | _a1933-0693 | ||
| 024 | 7 |
_a10.3171/2015.4.JNS15173 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aOstrem, Jill L | |
| 245 | 0 | 0 |
_aClinical outcomes using ClearPoint interventional MRI for deep brain stimulation lead placement in Parkinson's disease. _h[electronic resource] |
| 260 |
_bJournal of neurosurgery _cApr 2016 |
||
| 300 |
_a908-16 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAntiparkinson Agents _xadministration & dosage |
| 650 | 0 | 4 |
_aDeep Brain Stimulation _xadverse effects |
| 650 | 0 | 4 | _aElectrodes, Implanted |
| 650 | 0 | 4 | _aEquipment Failure |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aLevodopa _xadministration & dosage |
| 650 | 0 | 4 | _aMagnetic Resonance Imaging, Interventional |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 | _aNeuropsychological Tests |
| 650 | 0 | 4 |
_aParkinson Disease _xdrug therapy |
| 650 | 0 | 4 |
_aPostoperative Complications _xepidemiology |
| 650 | 0 | 4 | _aProspective Studies |
| 650 | 0 | 4 | _aQuality of Life |
| 650 | 0 | 4 |
_aSubthalamic Nucleus _xanatomy & histology |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aZiman, Nathan | |
| 700 | 1 | _aGalifianakis, Nicholas B | |
| 700 | 1 | _aStarr, Philip A | |
| 700 | 1 | _aLuciano, Marta San | |
| 700 | 1 | _aKatz, Maya | |
| 700 | 1 | _aRacine, Caroline A | |
| 700 | 1 | _aMartin, Alastair J | |
| 700 | 1 | _aMarkun, Leslie C | |
| 700 | 1 | _aLarson, Paul S | |
| 773 | 0 |
_tJournal of neurosurgery _gvol. 124 _gno. 4 _gp. 908-16 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.3171/2015.4.JNS15173 _zAvailable from publisher's website |
| 999 |
_c25382076 _d25382076 |
||